ANGO stock · CVS stock

ANGO vs CVS

AngioDynamics Inc (ANGO) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.

AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.

CVS Health Corp (CVS) is a healthcare plans company listed on US.

Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.

Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.

ANGO currently screens at market cap $378.5M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.

Not investment advice. Open the ANGO and CVS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons